Smooth Excimer Laser Coronary Angioplasty (SELCA) and conventional excimer laser angioplasty: Comparison of vascular injury and smooth muscle cell proliferation

被引:2
作者
Oberhoff, M [1 ]
Baumbach, A [1 ]
Herdeg, C [1 ]
Hassenstein, S [1 ]
Xie, DY [1 ]
Blessing, E [1 ]
Hanke, H [1 ]
Haase, KK [1 ]
Betz, E [1 ]
Karsch, KR [1 ]
机构
[1] UNIV TUBINGEN,DEPT PHYSIOL,D-72076 TUBINGEN,GERMANY
关键词
excimer laser; smooth muscle cell proliferation; bromodeoxyuridine; experimental atherosclerosis;
D O I
10.1007/BF02767155
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Although the excimer laser, which utilizes 'non-thermal ablation effects', has achieved encouraging results in early clinical trials, the long-term results have failed to show any advantage over conventional percutaneous transluminal coronary angioplasty (PTCA). A new system, Smooth Excimer Laser Coronary Angioplasty (SELCA), has been developed to reduce the tissue damage in the vessel wall caused by shock waves and vapour bubbles. SELCA (wavelength 308 nm, pulse duration 115 ns, repetition rate 150 Hz and energy density 50 mJ mm(-2)) lowers the amount of shock wave formation and pressure peak amplitude in the surrounding tissue by about eight times when compared to the conventional 308 nm excimer laser (ELCA). In this preclinical evaluation, this new system was compared to ELCA. Fifty New Zealand White rabbits were stimulated by repeated weak DC impulses for a period of 28 days in order to form an atherosclerotic plaque in the right carotid artery. The vessels were excised 3, 7, 14 and 28 days after laser irradiation for immunohistochemical analysis. SELCA and ELCA laser treatment lead to a decrease in maximal intimal wall thickness 3 days after intervention (control: 177 +/- 4 mu m; SELCA: 131 +/- 22 mu m; ELCA: 120 +/- 33 mu m). In the period between 3 and 28 days, a moderate increase in intimal wall thickness was observed after SELCA treatment compared to a significant increase after ELCA (28 days after intervention: SELCA: 157 +/- 22 mu m; ELCA: 274 +/- 28 mu m). Bromodeoxyuridine (BrdU) was applied 18 and 12h before excision of the vessels in order to determine the percent of cells undergoing DNA synthesis. The percent of BrdU labelled SMC in the intima (control: 13 +/- 2 cells mm(-2)) increased in both groups after 3 days (SELCA: 248 +/- 107 cells mm(-2); ELCA: 162 +/- 41 cells mm(-2)) and 7 days (SELCA: 162 +/- 55 cells mm(-2); ELCA: 279 +/- 119 cells mm(-2)). The present results demonstrate that vascular wall injury and increase in intimal wall thickness following SELCA are reduced in comparison to the results achieved with the conventional technique. Further trials are necessary to assess whether these improvements will lead to more favourable long-term results after excimer laser angioplasty.
引用
收藏
页码:328 / 335
页数:8
相关论文
共 33 条
[1]   Randomised trial of excimer laser angioplasty versus balloon angioplasty for treatment of obstructive coronary artery disease [J].
Appelman, YEA ;
Piek, JJ ;
Strikwerda, S ;
Tijssen, JGP ;
deFeyter, PJ ;
David, GK ;
Serruys, PW ;
Margolis, JR ;
Koelemay, MJ ;
vanSwijndregt, EWJM ;
Koolen, JJ .
LANCET, 1996, 347 (8994) :79-84
[2]   INFLUENCE OF ARTERIAL DAMAGE AND WALL SHEAR RATE ON PLATELET DEPOSITION - EXVIVO STUDY IN A SWINE MODEL [J].
BADIMON, L ;
BADIMON, JJ ;
GALVEZ, A ;
CHESEBRO, JH ;
FUSTER, V .
ARTERIOSCLEROSIS, 1986, 6 (03) :312-320
[3]  
BOWKER T J, 1986, Lasers in Medical Science, V1, P91, DOI 10.1007/BF02038956
[4]   PERCUTANEOUS EXCIMER LASER CORONARY ANGIOPLASTY OF LESIONS NOT IDEAL FOR BALLOON ANGIOPLASTY [J].
COOK, SL ;
EIGLER, NL ;
SHEFER, A ;
GOLDENBERG, T ;
FORRESTER, JS ;
LITVACK, F .
CIRCULATION, 1991, 84 (02) :632-643
[5]  
CROSS FW, 1986, CIRCULATION S11, V74
[6]   PULSED EXCIMER LASER ANGIOPLASTY OF HUMAN CADAVERIC ARTERIES [J].
FARRELL, EM ;
HIGGINSON, LAJ ;
NIP, WS ;
WALLEY, VM ;
KEON, WJ .
JOURNAL OF VASCULAR SURGERY, 1986, 3 (02) :284-287
[7]   PRELIMINARY-RESULTS OF INTRAOPERATIVE EXCIMER LASER ANGIOPLASTY - PHASE-1 - AN ADJUNCT TO CORONARY-ARTERY BYPASS-SURGERY [J].
FRAZIER, OH ;
DIETHRICH, EB ;
JOHANSSON, B ;
CONGER, JL ;
BURNETT, CM ;
BYLOCK, A ;
KADIPASAOGLU, KA .
LASERS IN SURGERY AND MEDICINE, 1992, 12 (01) :7-12
[8]   PULSED ULTRAVIOLET-LASERS AND THE POTENTIAL FOR SAFE LASER ANGIOPLASTY [J].
GRUNDFEST, WS ;
LITVACK, IF ;
GOLDENBERG, T ;
SHERMAN, T ;
MORGENSTERN, L ;
CARROLL, R ;
FISHBEIN, M ;
FORRESTER, J ;
MARGITAN, J ;
MCDERMID, S ;
PACALA, TJ ;
RIDER, DM ;
LAUDENSLAGER, JB .
AMERICAN JOURNAL OF SURGERY, 1985, 150 (02) :220-226
[9]   LASER ABLATION OF HUMAN ATHEROSCLEROTIC PLAQUE WITHOUT ADJACENT TISSUE-INJURY [J].
GRUNDFEST, WS ;
LITVACK, F ;
FORRESTER, JS ;
GOLDENBERG, T ;
SWAN, HJC ;
MORGENSTERN, L ;
FISHBEIN, M ;
MCDERMID, IS ;
RIDER, DM ;
PACALA, TJ ;
LAUDENSLAGER, JB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (04) :929-933
[10]   OCCURRENCE, EXTENT, AND IMPLICATIONS OF PRESSURE WAVES DURING EXCIMER-LASER ABLATION OF NORMAL ARTERIAL-WALL AND ATHEROSCLEROTIC PLAQUE [J].
HAASE, KK ;
HANKE, H ;
BAUMBACH, A ;
HASSENSTEIN, S ;
WEHRMANN, M ;
DUDA, S ;
ROSE, C ;
VONMUNCH, W ;
KARSCH, KR .
LASERS IN SURGERY AND MEDICINE, 1993, 13 (03) :263-270